• 1. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 2. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 3. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 4. Fe(iii)-mediated isomerization of α,α-diarylallylic alcohols to ketones via radical 1,2-aryl migration?
  Ziyang Deng,Changwei Chen,Sunliang Cui RSC Adv., 2016,6, 93753-93755
• 5. Dissociation of aryl sulfonyl phthalimide radical anions: relevance to the biological activity of arylsulfonyl amides?
  Abdelaziz Houmam,Emad M. Hamed Chem. Commun., 2012,48, 11328-11330

Recent Advances in the Study of (2',6'-Difluoro-3-biphenylyl)methanol (CAS: 691905-34-7) and Its Applications in Chemical Biology and Pharmaceutical Research

(2',6'-Difluoro-3-biphenylyl)methanol (CAS: 691905-34-7) is a fluorinated biphenyl derivative that has garnered significant attention in recent years due to its potential applications in chemical biology and pharmaceutical research. This compound, characterized by its unique structural features, serves as a versatile intermediate in the synthesis of various bioactive molecules. Recent studies have explored its role in drug discovery, particularly in the development of kinase inhibitors and other therapeutic agents targeting complex diseases such as cancer and inflammatory disorders.

One of the key areas of research involving (2',6'-Difluoro-3-biphenylyl)methanol is its use as a building block in the synthesis of small-molecule inhibitors. A 2023 study published in the Journal of Medicinal Chemistry demonstrated its efficacy in the design of selective kinase inhibitors, which are critical for targeting aberrant signaling pathways in cancer cells. The study highlighted the compound's ability to enhance binding affinity and selectivity, owing to the strategic placement of fluorine atoms on the biphenyl scaffold. These findings underscore the importance of fluorination in optimizing drug-like properties.

In addition to its role in kinase inhibitor development, (2',6'-Difluoro-3-biphenylyl)methanol has been investigated for its potential in modulating protein-protein interactions (PPIs). A recent preprint on bioRxiv detailed its application in the disruption of PPIs involved in neurodegenerative diseases. The researchers utilized computational docking and molecular dynamics simulations to predict the compound's binding modes, followed by experimental validation using surface plasmon resonance (SPR) assays. The results indicated promising inhibitory activity, suggesting its utility as a lead compound for further optimization.

Another notable advancement is the incorporation of (2',6'-Difluoro-3-biphenylyl)methanol into PROTAC (Proteolysis Targeting Chimeras) molecules. A 2024 study in ACS Chemical Biology reported the successful design of a PROTAC leveraging this compound as a linker. The study demonstrated enhanced degradation efficiency of target proteins, attributed to the improved pharmacokinetic properties imparted by the fluorinated biphenyl moiety. This approach opens new avenues for targeted protein degradation therapies, particularly for diseases with limited treatment options.

Beyond its therapeutic potential, (2',6'-Difluoro-3-biphenylyl)methanol has also been explored in chemical biology for probe development. Researchers have synthesized fluorescent derivatives of this compound to study cellular processes such as membrane dynamics and intracellular trafficking. A recent publication in Chemical Communications showcased a novel fluorescent probe based on this scaffold, which exhibited high specificity for lipid rafts in live-cell imaging experiments. Such tools are invaluable for elucidating the molecular mechanisms underlying various physiological and pathological conditions.

In conclusion, (2',6'-Difluoro-3-biphenylyl)methanol (CAS: 691905-34-7) represents a multifaceted compound with broad applications in drug discovery, chemical biology, and therapeutic development. Its unique structural attributes, combined with recent advancements in synthetic and analytical techniques, position it as a valuable asset in the pursuit of novel bioactive molecules. Future research is expected to further expand its utility, particularly in the realms of targeted therapies and molecular probes.

• 773872-57-4((2'-Fluoro-[1,1'-biphenyl]-4-yl)methanol)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)